抽象的
Novel oral taxane therapies: recent Phase I results
John Paul Flores, M Wasif SaifThe oral taxanes are analogues of existing taxanes with a possible broad range of antitumor activity. They also have the potential advantages of ease of administration, better efficacy and lesser toxicity than currently available taxanes. These drugs have been used in several Phase I clinical trials, the methodology and results of which will be reviewed here.
免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证